Concorde International Group Ltd.
NASDAQ:CIGLSpecialty Business Services
-$0.01 today
- Market cap
- $51.77M
- Beta
- 2.72
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$0.56
Volume 4.05M
Average 2.56M
CIGL Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Concorde International Group Ltd.NASDAQ: CIGL
Operating Margin · Q4 FY2025 · quarter ended Dec 2025
Operating margin at -191.4%
Operating margin was -191.4% in Q4 FY2025.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -122.5%
- Year-over-year change
- —
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -122.5% | — |
Operating Margin vs competitors
How CIGL compares with its peers on the latest reported figures
No competitor Operating Margin figures are available to compare.
Income Statement
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 12.48M |
| Cost of Revenue | 22.26M |
| Gross Profit | (9.79M) |
| Gross Margin | -78.4% |
| Research & Development | 0 |
| Selling, General & Admin | 5.5M |
| Operating Expenses | 5.5M |
| Depreciation & Amortization | 589.98K |
| EBITDA | (14.69M) |
| EBITDA Margin | -117.8% |
| Operating Income | (15.28M) |
| Operating Margin | -122.5% |
| Interest Income | 28.22K |
| Interest Expense | 296.15K |
| Other Income / Expenses | 179.71K |
| Income Before Tax | (15.11M) |
| Pre-Tax Margin | -121.1% |
| Income Tax Expense | 97.14K |
| Net Income | (15.24M) |
| Net Margin | -122.2% |
| EPS (Basic) | (0.56) |
| EPS (Diluted) | (0.56) |
| Weighted Avg Shares | 26.99M |
| Weighted Avg Shares (Diluted) | 26.99M |
Concorde International Group Ltd.
NASDAQ:CIGL
Intrinsic Alpha fair value
Locked
Current Price
$0.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.